Food supplements are often perceived as a less regulated market compared to pharmaceuticals. This idea is widespread, both among consumers and some industry stakeholders. However, the regulation of food supplements in Europe is very real and based on strict requirements, particularly regarding safety, labeling, and health claims.
So, are food supplements less regulated? The answer is more nuanced than it appears.
Regulation of Food Supplements in Europe: What Framework?
In Europe, food supplements fall under food law and are governed by Directive 2002/46/EC. They must comply with several key requirements:
- Safety of ingredients used
- Maximum permitted dosages
- Labeling rules
- Approved health claims
Health claims are strictly evaluated by the European Food Safety Authority (EFSA), which requires robust scientific evidence before authorization.
Official references:
https://eur-lex.europa.eu/legal-content/FR/TXT/?uri=CELEX:32002L0046
https://eur-lex.europa.eu/legal-content/FR/ALL/?uri=CELEX:02006R1924-20121129
In France, market surveillance is carried out by the “Direction générale de la concurrence, de la consommation et de la répression des fraudes (DGCCRF)”.
The regulation of food supplements in Europe is therefore structured and robust, even if it differs from pharmaceutical regulation.
A Different Model from Medicines Regulation
Unlike medicinal products, food supplements do not require a marketing authorization (MA) before being placed on the market.
However, this does not mean there is no control.
The system relies on:
- Manufacturer responsibility
- Post-market controls by authorities
- The possibility of product withdrawal in case of non-compliance
The regulation of food supplements in Europe follows a different logic, but it is not more permissive.
Food Supplements and Clinical Trials: A Gradual Evolution
Food supplements do not systematically require clinical trials for commercialization. However, industry practices are evolving.
More and more manufacturers are conducting studies to:
- Strengthen scientific credibility
- Support health claims
- Differentiate themselves in a competitive market
In some cases, these studies are inspired by standards from EU Regulation 536/2014, even though they do not formally fall within this regulatory framework.
In France, certain studies involving food supplements may fall under research “outside health products,” supervised by “the Agence nationale de sécurité du médicament et des produits de santé”. This category includes studies that are not related to medicines or medical devices but may still involve human investigations.
This trend highlights how the regulation of food supplements in Europe is increasingly associated with higher expectations for scientific evidence.
Between Regulation and Scientific Strategy
One of the main challenges lies in balancing:
- Regulatory requirements
- Market expectations
- Scientific evidence levels
Health claims must be validated, but obtaining approval often requires complex and costly scientific data.
This creates a situation where the regulation of food supplements in Europe imposes strict rules while leaving some room for interpretation by manufacturers.
Nutrition and Health Claims: A Strict European Framework
The regulation of food supplements in Europe also includes a precise framework for nutrition and health claims.
As highlighted by the official European Union portal, only authorized claims may be used, and they must meet strict scientific criteria. Companies must demonstrate that their products provide a clearly established beneficial effect, and marketing claims must remain consistent with approved lists.
In practice, this significantly limits the type of messages that can be used and ensures consistency between communication and scientific evidence.
An Accessible Market, but with Constraints
The absence of a marketing authorization requirement may give the impression that the market is easier to access.
In reality, the regulation of food supplements in Europe involves:
- Significant manufacturer responsibility
- Ongoing regulatory oversight
- Risk of reclassification as a medicinal product
A product claiming therapeutic effects may be reclassified as a medicine, leading to major regulatory consequences.
Conclusion: A Different but Structuring Regulation
Food supplements are not less regulated—they are regulated differently.
The regulation of food supplements in Europe is based on a balance between safety, consumer information, and manufacturer responsibility.
In this context, companies have a strong interest in adopting a rigorous scientific approach, including clinical studies, to secure their products and strengthen their market positioning.
